home / stock / krys / krys articles

KRYS Articles, Krystal Biotech Inc.

Stock Information
Company Name: Krystal Biotech Inc.
Stock Symbol: KRYS
Market: NASDAQ
Website: krystalbio.com
Menu
KRYS KRYS Quote KRYS Short KRYS News KRYS Articles KRYS Message Board
Get KRYS Alerts

News, Short Squeeze, Breakout and More Instantly...
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years | Benzinga

Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 19.32% on an annualized basis producing an average annual return...
ICC Holdings, Diamond Offshore Drilling, CrowdStrike And Other Big Stocks Moving Higher On Monday | Benzinga

U.S. stocks were mixed, with the Dow Jones index falling around 0.2% on Monday. Shares of ICC Holdings, Inc. (NASDAQ:ICCH) rose sharply during Mond...

Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference | Benzinga

PITTSBURGH, June 05, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS), a commercial-stage biotechnology company, tod...

Candel Reports Upbeat Data From Lung Cancer Study | Benzinga

Candel Therapeutics, Inc. (NASDAQ: CADL) announced overall survival data from a phase II study evaluating its lead investigational adenovirus immun...
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference | Benzinga

PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS), a commercial-stage biotechnology company, anno...

Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024 | Benzinga

PITTSBURGH, April 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS), a commercial-stage biotechnology company, to...

Krystal Biotech is on the Move, Here's Why the Trend Could be Sustainable | Benzinga

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of ...
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting | Benzinga

PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS), a commercial-stage biotechnology company, an...

Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards | Benzinga

-- Hubert Chen, accomplished drug developer and pharma executive, joins as Chief Medical Officer -- Industry veterans and leading academic experts...

$100 Invested In This Stock 5 Years Ago Would Be Worth $800 Today | Benzinga

Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 40.23% on an annualized basis producing an average annual return...
Next 10